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4 (red) corresponded to high level of severity. For our analysis
we combined zones 1 and 2 into a “low severity” class whereas
zones 3 and 4 were combined into a “high severity” class. Our
goal was to build predictive rules which allow forecasting of the
severity class one day ahead of time using methods of artiﬁcial
intelligence. We used dependent variables from a day N to
predict the severity class on the day N + 1. Overall, 7001 records
collected from 26 asthma patients were used in this analysis.
Classiﬁcation and Regression Trees (CART) algorithm was
employed to develop three predictive models. Model I utilized
all predictive variables, model II employed only 3 variables iden-
tiﬁed by CART as the most powerful predictors, and model III
used only asthma symptom variables. RESULTS: The CART
algorithm prioritized three predictor variables (normalized
number of puffs of quick relief inhaler, normalized PEF, and
asthma symptom score) based on their level of inﬂuence on the
“asthma severity class” variable. The resulting forecast rules
yielded good overall prediction success rates from both the learn-
ing (87.2%; 98.6%; 96.2%) and testing (86%; 96.5%; 95.2%)
samples of models I, II, III respectively. Moreover, it generated
63 decision rules accurately characterizing both “low” and
“high” severity classes. CONCLUSIONS: CART algorithms
showed acceptable accuracy in forecasting asthma 
exacerbations.
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OBJECTIVE: The high prevalence of asthma has emerged as a
major public health issue. It has been shown that patient educa-
tion on self-management is an essential and effective component
of chronic illness management. The objective of the current study
was to report on outcomes associated with implementation of
an automated patient self-management system, ALERTS©, in a
primary care group practice—ProHealth Physicians (PHP).
METHODS: A pre/post design was employed. Patients were
identiﬁed using PHP’s billing database. ALERTS© was accessed
via the Internet or via a toll-free number. Patients were given real-
time feedback regarding their symptom zone and actions to take
based on their Asthma Action Plan. ALERTS© made reports on
patients’ peak ﬂow meter (PFM) readings available to patients
and their providers. Outcomes assessed included unscheduled
outpatient visits, emergency room (ER) visits, days lost from
work/school, medication prescriptions, and number of outpa-
tient procedures. Comparisons of pre/post intervention outcomes
were calculated using the paired t-test, McNemar’s test for
dichotomous data and Chi-Square as a comparison of propor-
tions. RESULTS: Seventy-four participants were enrolled.
Patients demonstrated reductions in the number of unscheduled
ofﬁce visits (p = 0.033) when comparing these prior to and after
ALERTS© use. Additionally, 55.9% (33/59) of participants saw
an increase in their personal best PFM measurement (p < 0.001);
100% (6/6) of participants under the age of 18 saw an increase
in this parameter (p = 0.027). Furthermore, participants answer-
ing the question reported missing less school/work due to their
asthma (p = 0.026). There was also a trend towards reduction
in limited physical activity, ER visits and prednisone use. CON-
CLUSION: ALERTS© was successfully implemented in a multi-
site group practice, proving to be a useful program for improving
care of chronic asthmatic patients.
ASTHMA—Methods and Concepts
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OBJECTIVE: Discrete choice models are widely used in phara-
macoeconomics. If correctly applied, bootstrapping is a useful
tool for these models because small sample distributions of the
dependent variables are not known. In this paper, we will show
how to apply bootstrapping to have consistent and efﬁcient 
estimators under discrete choice models. METHOD: Four
common bootstrapping techniques were analyzed: paired, non-
parametric, parametric, and wild bootstrapping. The extension
of parametric bootstrapping for linear regression to parametric
discrete choice models is presented: Let U be the probability that
the binary dependent variable y = 1. Then for each application
we choose y*, which is the new independent variable for each
bootstrap, from Bernoulli distribution with probability of
success given by U. RESULTS: The Market Scan® private insur-
ance database was used in this study. The analytic sample com-
prised 36,341 individuals with asthma whose healthcare was
provided under a variety of fee-for-service (FFS), fully capitated,
and partially capitated health plans. We estimated hospitaliza-
tion for FFS and non-FFS asthma patients. Logit models were
selected depending on the distribution of the dependent variable.
The Pearson chi-square goodness of ﬁt test (p = 0.3742) and the
Hosmer and Lemeshow test (p = 0.2904) suggested that 
the model ﬁt well. Treatment patterns had no signiﬁcant effect
on hospitalization after controlling for demographic and clinical
factors. The illness severity of the patient (proxied by the number
of three-digit ICD-9 codes), however, had a positive and signiﬁ-
cant effect on hospitalization. We would not have seen this sig-
niﬁcant effect if we had chosen paired, non-parametric, or wild
bootstrapping as a way to bootstrap standard errors. CON-
CLUSION: Despite the obvious beneﬁt of bootstrapping in dis-
crete choice models, the method should not be used blindly. Once
the model is estimated under parametric assumptions, as in logit
or probit models, deviations of the assumptions for bootstrap-
ping will yield inefﬁcient estimators.
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OBJECTIVES: The St. George’s Respiratory Questionnaire
(SGRQ) is a disease-speciﬁc instrument used to measure health-
related quality of life (HRQoL) in patients with asthma. It is a
76-item questionnaire comprised of three domains: symptoms,
activities, and impact. We conducted a systematic review to
determine the psychometric measurement properties.
METHODS: We used the search terms “St. George’s Respiratory
Questionnaire” and “St. George’s Respiratory Questionnaire
and asthma”. All published papers and abstracts were reviewed
and assessed using MEDLINE 1966–2005, April Week 2 and
OVID full-text via the University of Southern California library
database and Google Scholar. Citations for all abstracts and arti-
cles citing the ﬁrst validation study were identiﬁed using the
Science Citation Index. Inclusion criteria included clinical trials
and observational studies reporting measurement properties in a
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population with asthma. RESULTS: We found 18 articles that
met the inclusion criteria; three were validation studies and the
remaining were observational studies or clinical trials. All three
domains of the SGRQ are internally consistent and reliable with
ICC of at least 0.70 for individual domains and greater than 0.90
for total score. Convergence and discriminate validity were seen
with two of three domains and dyspnea grade, six-minute walk
distance, and other HRQoL instruments. Face and content valid-
ity were demonstrated. SGRQ was able to discriminate between
patients with varying levels of symptoms, FEV1, self-reported
healthcare utilization services, asthma control problems, and
HRQoL. Responsiveness to change, however, is not well-
established for SGRQ despite a reported minimally important
difference of 3.9-unit change, which may be due partly to a
paucity of studies using SGRQ in this population. CONCLU-
SIONS: Our ﬁndings suggest SGRQ has face, content, and con-
struct validity. It is able to discriminate between different groups
of asthma patients, and may be useful in facilitating asthma
resource allocation. Further research is needed to determine its
responsiveness to change.
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OBJECTIVE: We applied the extension of propensity score
methodology that allows for estimation of average causal effects
with multi-valued treatment. METHODS: The methodology
requires three steps: 1. Estimating propensity score with multin-
omial or nested logit 2. Estimating the conditional expectation
and 3. estimate average respond treatment by calculating average
of conditional expectation averaged over the distribution of the
pre-treatment variables. RESULTS: The Market Scan private
insurance data base was used in this study which based upon
asthma individuals whose health care was provided under a
variety of fee-for-service (FFS), fully capitated and partially cap-
itated health plans, including exclusive provider organizations,
indemnity plans. Treatment is divided into three categories: a)
controller only; b) reliver only; and c) reliever and controller.
These three categories is matched with control group using mul-
tionomial logit. Pre-period demographic and clinical factors are
used as a covariate. Conditional expectations are calculated and
applied as a weight to estimate average treatment effect among
asthma patients. Reliever and Controller patients have 
the highest treatment effect whereas controller only patients have
the lowest effect. CONCLUSION: Multi-valued treatment is
common in pharmacoeconomical research and extension of
propensity score matching to cover multi-valued treatment is
straightforward and easy to apply.
ASTHMA—Patient Reported Outcomes
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OBJECTIVE: To assess the patterns of persistence with various
classes of inhaled medications (i.e., beta agonist, anticholinergic,
and glucocorticoid) medications used to treat asthma and
chronic obstructive pulmonary disease (COPD). METHODS:
Pharmacy claims data were analyzed for persistence with inhaled
treatment (time to discontinuation) using a 60-day gap to deﬁne
discontinuation. Compliance, deﬁned as the percentage of days
with doses available divided by days to last reﬁll, also was
assessed. Patients were grouped as naïve (no inhaled medication
in the previous year) or experienced (previous or current treat-
ment), and by age (18–65, 65+ years). Medications included:
ipratropium, ipratropium + salbutamol, formoterol, formoterol
+ budesonide, salmeterol, salmeterol + ﬂuticasone, and
tiotropium. RESULTS: The database included 31,368 patients
prescribed one of these medications (4,888 naïve, 26,480 expe-
rienced). Based on a 60-day lapse in reﬁll, only 15–63% of
patients continued on the index drug for more than 6 months,
further decreasing to 7–53% at 12 months, and 5–47% at 18
months. At 12 months, patients taking tiotropium had signiﬁ-
cantly longer persistence rates compared to that for other drugs
(53% versus 7–30%, all p < 0.0001), and fewer switches to alter-
native medications. Naïve patients had signiﬁcantly shorter treat-
ment persistence than experienced patients for all drugs (all p <
0.0001), including tiotropium (27% versus 55%, p < 0.0001).
Compliance rates were similar for all drugs (i.e., 76%–94%) but
highest for tiotropium. CONCLUSIONS: These data demon-
strated that 1) persistence with inhaled treatment for asthma and
COPD was low overall (despite the generous 60-day allowance
to reﬁll), but patients stayed on treatment with tiotropium sig-
niﬁcantly longer than with other medications, and 2) patients
naïve to these classes of inhaled treatment had shorter treatment
persistence than experienced patients.
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Asthma is a chronic inﬂammatory disorder of the lungs and has
a signiﬁcant impact on morbidity, mortality, and health-related
quality of life (HRQL). Asthma also impacts indirect costs result-
ing from losses in workplace productivity. OBJECTIVE: To
examine the association of medication adherence with workplace
productivity and HRQL in patients with asthma in a state health
insurance program. METHODS: The diagnosis of asthma was
identiﬁed from medical claims data of state employees between
18 and 65 years of age who obtained healthcare beneﬁts from a
state health insurance program from July 2001 through June
2003. A three-part survey was mailed to these patients to
measure HRQL, workplace productivity, (absenteeism [time lost
from work] and presenteeism [reduced productivity at work]),
and self-reported medication adherence. The survey consisted of
the St. George’s Respiratory Questionnaire, the Workplace Pro-
ductivity Short Inventory, and the Morisky Adherence Scale. Pro-
ductivity losses were translated into dollar values by using
previously published metrics (employer perspective). The associ-
ation between self-reported medication adherence and HRQL
and productivity was measured using multivariate regression
analyses. RESULTS: The response rate was 25.1% (385/1493).
The mean HRQL total summary score was 33.2 ± 19.9 units,
with the symptoms domain having the worst HRQL scores (49.3
± 21.4 units), followed by the activity (39.6 ± 26.6) and impacts
(24.6 ± 19.1) domains. 39% of the participants reported them-
selves as “high” adherent, 19% reported themselves as
“medium” adherent, and 42% as “low” adherent. Asthma
resulted in productivity losses of $597 ± $1024 (absenteeism)
